ANATOMIC STAGE IIIB BREAST CANCER AJCC V8
Clinical trials for ANATOMIC STAGE IIIB BREAST CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new ANATOMIC STAGE IIIB BREAST CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for ANATOMIC STAGE IIIB BREAST CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New vaccine aims to train immune system against aggressive breast cancer
⭐️ VACCINE ⭐️ OngoingThis study tests a DNA-based vaccine called STEMVAC in 33 people with early-stage triple negative breast cancer (stages IB to III). The vaccine targets proteins found on breast cancer stem cells and aims to train the immune system to recognize and attack these cells. The main goa…
Matched conditions: ANATOMIC STAGE IIIB BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: University of Washington • Aim: ⭐️ VACCINE ⭐️
Last updated May 22, 2026 14:03 UTC
-
New drug combo aims to stop aggressive breast Cancer's return
Disease control OngoingThis phase 3 trial tests whether adding tucatinib to the standard drug T-DM1 can better prevent HER2-positive breast cancer from returning in high-risk patients. About 1,056 participants who still have cancer after initial treatment will receive either T-DM1 alone or T-DM1 plus t…
Matched conditions: ANATOMIC STAGE IIIB BREAST CANCER AJCC V8
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 26, 2026 05:07 UTC
-
New drug cocktail shows promise in shrinking HER2+ breast tumors before surgery
Disease control OngoingThis study tests a combination of targeted drugs (ribociclib, tucatinib, trastuzumab) with or without hormone therapy (fulvestrant) for HER2-positive breast cancer. In the first part, it checks safety in patients whose cancer has spread. In the second part, it compares this combo…
Matched conditions: ANATOMIC STAGE IIIB BREAST CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
Immunotherapy combo offers new hope for tough breast cancer cases
Disease control OngoingThis study tests whether adding the immunotherapy drug pembrolizumab to hormone therapy and radiation can help prevent recurrence in people with hormone receptor-positive inflammatory breast cancer. Participants had chemotherapy before surgery, but their cancer did not completely…
Matched conditions: ANATOMIC STAGE IIIB BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
New web tool aims to ease life for young breast cancer survivors
Symptom relief OngoingThis study tests a web-based portal called YES that helps young breast cancer survivors track symptoms and find resources. About 400 women aged 15-39 who had early-stage breast cancer will use the portal or get standard care. The goal is to see if the portal improves quality of l…
Matched conditions: ANATOMIC STAGE IIIB BREAST CANCER AJCC V8
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated May 26, 2026 05:12 UTC
-
Writing away the pain: new study for chinese breast cancer survivors
Symptom relief OngoingThis study tests whether a culturally tailored expressive writing program can improve quality of life for Chinese immigrant women who had breast cancer. About 256 women who finished treatment within the last 5 years will write about their experiences. Researchers will measure cha…
Matched conditions: ANATOMIC STAGE IIIB BREAST CANCER AJCC V8
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 26, 2026 05:11 UTC
-
Walking through chemo: new study tests exercise for seniors with breast cancer
Symptom relief OngoingThis study looks at whether a simple exercise program—walking and arm exercises—is doable for women aged 65 and older while they receive chemotherapy for early-stage breast cancer. About 30 participants will be asked to exercise several times a week during their treatment. The go…
Matched conditions: ANATOMIC STAGE IIIB BREAST CANCER AJCC V8
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 22, 2026 13:53 UTC
-
Scientists build model to predict chemo nerve damage
Knowledge-focused OngoingThis study looks at over 1,300 cancer patients to find out who is more likely to develop nerve damage (tingling or numbness in hands and feet) from taxane chemotherapy. Researchers will track factors like age, gender, and pre-existing conditions to create a prediction tool. The g…
Matched conditions: ANATOMIC STAGE IIIB BREAST CANCER AJCC V8
Sponsor: SWOG Cancer Research Network • Aim: Knowledge-focused
Last updated May 26, 2026 05:12 UTC
-
Cancer survivors share fertility hopes in landmark survey
Knowledge-focused OngoingThis study surveys women aged 18-45 who have had gynecological or breast cancer to learn how they think about having children after cancer. Researchers will use the results to help future patients make informed decisions about treatment and family planning. The study involves foc…
Matched conditions: ANATOMIC STAGE IIIB BREAST CANCER AJCC V8
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 05:10 UTC
-
New study tracks shoulder pain after breast cancer radiation
Knowledge-focused OngoingThis study looks at shoulder and arm problems in people with lymph-node positive breast cancer who receive radiation therapy. About 61 participants will be followed for one year after treatment to see how often shoulder issues occur with two different radiation techniques. The go…
Matched conditions: ANATOMIC STAGE IIIB BREAST CANCER AJCC V8
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 05:04 UTC
-
Genetic test may predict chemo nerve pain in black women
Knowledge-focused OngoingThis study looks at whether a genetic test can identify African American women with breast cancer who are more likely to develop nerve damage from taxane chemotherapy. Researchers compare two chemo drugs, docetaxel and paclitaxel, to see which causes fewer nerve problems. About 2…
Matched conditions: ANATOMIC STAGE IIIB BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Knowledge-focused
Last updated May 26, 2026 04:34 UTC
-
Gene test may guide breast cancer treatment choices
Knowledge-focused OngoingThis study looks at whether testing tumor genes can help predict if HER2-negative breast cancer will respond to standard treatments like chemotherapy or hormone therapy. About 1,100 people with early-stage breast cancer (stages I to III) will have their tumor samples analyzed. Th…
Matched conditions: ANATOMIC STAGE IIIB BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 20, 2026 11:53 UTC
-
New study aims to help older breast cancer patients make chemotherapy choices
Knowledge-focused OngoingThis study looks at how women aged 65 and older with early-stage breast cancer make decisions about chemotherapy. Researchers will interview patients and doctors to understand what information they need. The goal is to create a tool that helps patients and doctors weigh the risks…
Matched conditions: ANATOMIC STAGE IIIB BREAST CANCER AJCC V8
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 18, 2026 12:00 UTC